| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers B > Headlines for BioScrip, Inc. > News item |
BioScrip ‘confident’ it will record $75 million of EBITDA for 2018
By Devika Patel
Knoxville, Tenn., Aug. 7 – BioScrip, Inc. expects it will generate at least $75 million of adjusted EBITDA in 2018.
“We are increasingly confident in our ability to deliver a minimum of $75 million of adjusted EBITDA in 2018,” president and chief executive officer Daniel E. Greenleaf said on the company’s second quarter ended June 30 earnings conference call on Tuesday.
Adjusted EBITDA was $11.4 million, 14% higher than the prior year quarter.
Liquidity was $20.82 million as of June 30, consisting of cash and cash equivalents.
BioScrip is a Denver-based provider of infusion and home care management solutions.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.